FN1 and cancer: Since oncofetal FNs are known to exhibit little to no protein expression in healthy normal tissues, the results from this study suggest that oncofetal FN presents a tumor-selective biomarker that can be exploited for targeted diagnostic and therapeutic agents for a multitude of cancers.